Education
About Us
Working with TipRanks
Follow Us
908 Devices (MASS)
NASDAQ:MASS
MASS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.81 - $7.48
Previous CloseN/A
Volume74.64K
Average Volume (3M)5.57M
Market Cap
$132.13M
Enterprise Value$55.80M
Total Cash (Recent Filing)$44.03M
Total Debt (Recent Filing)$6.61M
Price to Earnings (P/E)―
Beta1.62
Next Earnings
May 13, 2025EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.11
Shares Outstanding35,329,994
10 Day Avg. Volume814,379
30 Day Avg. Volume5,565,009
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.68
Price to Cash Flow (P/CF)-17.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.87
Enterprise Value/Ebitda-0.83
Forecast
1Y Price Target
$5.67Price Target Upside48.82% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
---
908 Devices News
PremiumCompany Announcements
908 Devices Inc. Reports Strategic Transformation and Growth
---
Bulls Say, Bears Say
Bulls Say
Market Positioning908 Devices is uniquely positioned to benefit from the increased commitment to addressing the fentanyl crisis, carcinogens, and overall security concerns.
Strategic FocusThe divestment of bioprocessing desktop assets increases the company's focus on its faster-growing and more profitable handheld portfolio.
Valuation OpportunityThe company's valuation is at 0.7 times sales, significantly lower than the peer average, which presents a potential investment opportunity.
Bears Say
Financial ConcernsThe company had a roughly $20 million operating loss.
Funding And Demand RecoveryThe analyst remains cautious until there is greater confidence in the funding outlook and demand recovery for handheld devices.
Market HeadwindsThe bioprocessing environment has been challenging and 908 had subscale commercial infrastructure at a time when its products still required evangelization.
---
Ownership Overview
24.87% Insiders
14.25% Mutual Funds
15.87% Other Institutional Investors
29.30% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MASS FAQ
What was 908 Devices’s price range in the past 12 months?
908 Devices lowest stock price was $1.81 and its highest was $7.48 in the past 12 months.
What is 908 Devices’s market cap?
908 Devices’s market cap is $132.13M.
When is 908 Devices’s upcoming earnings report date?
908 Devices’s upcoming earnings report date is May 13, 2025 which is in 37 days.
How were 908 Devices’s earnings last quarter?
908 Devices released its earnings results on Mar 04, 2025. The company reported -$0.56 earnings per share for the quarter, missing the consensus estimate of -$0.345 by -$0.215.
Is 908 Devices overvalued?
According to Wall Street analysts 908 Devices’s price is currently Undervalued.
Does 908 Devices pay dividends?
908 Devices does not currently pay dividends.
What is 908 Devices’s EPS estimate?
908 Devices’s EPS estimate is -0.29.
How many shares outstanding does 908 Devices have?
908 Devices has 35,329,994 shares outstanding.
What happened to 908 Devices’s price movement after its last earnings report?
908 Devices reported an EPS of -$0.56 in its last earnings report, missing expectations of -$0.345. Following the earnings report the stock price went up 95.96%.
Which hedge fund is a major shareholder of 908 Devices?
Currently, no hedge funds are holding shares in MASS
---
908 Devices Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$5.67 (48.82% Upside)
$5.67 (48.82% Upside)
Blogger Sentiment
Bullish
MASS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 708.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 15.4%
Last 30 Days ▲ 15.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-41.38%
12-Months-Change
Fundamentals
Return on Equity
-51.56%
Trailing 12-Months
Asset Growth
-21.43%
Trailing 12-Months
Company Description
908 Devices
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
---
MASS Company Deck
---
MASS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with notable revenue growth and successful integration of RedWave Technology but was overshadowed by financial results falling short of expectations, lowered revenue guidance, and a significant goodwill impairment charge. Cost-saving measures and strategic adjustments are in place, yet market softness and governmental delays pose challenges.Read More>---
MASS Stock 12 Month Forecast
Average Price Target
$5.67
▲(48.82% Upside)
Technical Analysis
Best Analysts Covering MASS
1 Year
1 Year Success Rate
2/10 ratings generated profit
1 Year Average Return
-29.84%
reiterated a buy rating last month
Copying Daniel Arias's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -29.84% per trade.
---